Skip to main content

Controversies in ILD

Sep 18, 2025 7:51 am
This deep dive into controversies in interstitial lung disease explored complex topics including IPAF, methotrexate, systemic autoimmune rheumatic disease vs. connective tissue disease distinctions, and the evolving role of anti-fibrotic therapy. Panelists: Jeffrey Sparks, MD, Janet Pope, MD, Elena Joerns, MD Jack Cush, MD - Moderator

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

×